Improved process control through sugar analysis of oat drinks
Oat drinks are the most popular plant-based milk alternative in the EU and the No. 2 in the US.
Sales figures of oat drinks are experiencing growth rates in the range of 20 – 30 % per year. Due to the increasing consumer demand, growth rates are expected to stay in this range. The sugar concentration and sweetness are important quality features for this product category. Sugar concentration must be considered for nutrition labelling and provides important insights into the stability of the production process and the storage stability of the oat drink. There are also oat drink manufacturers that offer sugar-free oat drinks. For sugar-free products the sugar content (sum of the mono- and disaccharides) must be < 0.5%.

Consumer preferences regarding the sweetness of an oat drink vary
In Northern Europe, oat drinks with low sweetness are preferred. In Central Europe drinks with a mild sweetness and in Southern Europe drinks with a high sweetness are preferred. This rapid growth confronts oat drink producers with new challenges, for instance ramping up production capacities as quickly as possible. Especially when producing at several production sites, it is essential that manufacturers ensure the consistent quality and taste of their products. Rapid sugar analysis helps oat drink producers to master these challenges. learn more at www.oat-sens.com
About DirectSens
Founded in 2013 as a spin-off from the University of Natural Resources and Life Sciences, Vienna (or BOKU, for short), DirectSens manufacturers and distributes a range of third-generation biosensors that do not require mediators by using enzymes capable of direct electrode transfer (DET).
DirectSens operates across various divisions, including quality management, electrochemistry, enzyme engineering, and manufacturing. This holistic approach ensures excellence throughout biosensor development—from research to manufacturing and customer support.
The company has recently turned its attention towards human health, launching XpressGT, a platform capable of accurately measuring 2-hydroxybutyrate, an organic substance with links to several endocrine system related diseases.
Related Insights
Explore more from our latest news, technology updates, and industrial resources.

DirectSens® Presents State-of-the-Art Analytical Biotechnology Solutions at Analytica 2026

DirectSens’ Market-Leading LactoSens® BioSensor Technology acquired by Kerry Group P.L.C.

A Breakthrough for Women’s Health: DirectSens Launches XpressGT to Combat Gestational Diabetes and More

End-to-End Biosensor Solutions
